Evogene's stock surged on news of ICL's acquisition of Lavie Bio's operations, strengthening ICL's position in ag-biologicals ...

ICL Group (ICL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Evogene (EVGN) signed a definitive agreement under which ICL will acquire the majority of activity of Evogene’s subsidiary, Lavie Bio. As part ...

ICL plans to acquire ag-biochemical tech firm Lavie Bio from Evogene Ltd. Lavie Bio is a recognized leader in the ag-biologicals industry with a robust pipeline of microbiome-based products.

1 Day ICL 0.79% DJIA -1.32% S&P 500 0.14% Basic Materials/Resources -1.48% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

ICL currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. DuPont de Nemours, Inc. DD logged adjusted earnings of $1.18 per ...

Zacks Investment Research ICL currently carries a Zacks Rank #2 (Buy). Other top-ranked stocks in the basic materials space are Carpenter Technology Corporation CRS, CF Industries Inc. CF and New ...

ICL Group Ltd. engages in the manufacture of mineral-based products for the agriculture, food, and engineered materials markets. Its products include potash and phosphate fertilizers, specialty ...